Lantibiotic epilancin 15X
Need Assistance?
  • US & Canada:
    +
  • UK: +

Lantibiotic epilancin 15X

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Lantibiotic epilancin 15X is an antibacterial peptide isolated from Staphylococcus epidermidis. It has activity against gram-positive bacteria.

Category
Functional Peptides
Catalog number
BAT-012563
Synonyms
Ser-Ala-Ser-Ile-Val-Lys-Thr-Thr-Ile-Lys-Ala-Ser-Lys-Lys-Leu-Cys-Arg-Gly-Phe-Thr-Leu-Thr-Cys-Gly-Cys-His-Phe-Thr-Gly-Lys-Lys
Sequence
SASIVKTTIKASKKLCRGFTLTCGCHFTGKK
1. Biosynthesis of the antimicrobial peptide epilancin 15X and its N-terminal lactate
Juan E Velásquez, Xingang Zhang, Wilfred A van der Donk Chem Biol. 2011 Jul 29;18(7):857-67. doi: 10.1016/j.chembiol.2011.05.007.
Lantibiotics are ribosomally synthesized and posttranslationally modified antimicrobial peptides. The recently discovered lantibiotic epilancin 15X produced by Staphylococcus epidermidis 15X154 contains an unusual N-terminal lactate group. To understand its biosynthesis, the epilancin 15X biosynthetic gene cluster was identified. The N-terminal lactate is produced by dehydration of a serine residue in the first position of the core peptide by ElxB, followed by proteolytic removal of the leader peptide by ElxP and hydrolysis of the resulting new N-terminal dehydroalanine. The pyruvate group thus formed is reduced to lactate by an NADPH-dependent oxidoreductase designated ElxO. The enzymatic activity of ElxB, ElxP, and ElxO were investigated in vitro or in vivo and the importance of the N-terminal modification for peptide stability against bacterial aminopeptidases was assessed.
2. Chemical synthesis and biological activity of analogues of the lantibiotic epilancin 15X
Patrick J Knerr, Wilfred A van der Donk J Am Chem Soc. 2012 May 9;134(18):7648-51. doi: 10.1021/ja302435y. Epub 2012 Apr 30.
Lantibiotics are a large family of antibacterial peptide natural products containing multiple post-translational modifications, including the thioether structures lanthionine and methyllanthionine. Efforts to probe structure-activity relationships and engineer improved pharmacological properties have driven the development of new methods to produce non-natural analogues of these compounds. In this study, solid-supported chemical synthesis was used to produce analogues of the potent lantibiotic epilancin 15X, in order to assess the importance of several N-terminal post-translational modifications for biological activity. Surprisingly, substitution of these moieties, including the unusual N-terminal D-lactyl moiety, resulted in relatively small changes in the antimicrobial activity and pore-forming ability of the peptides.
3. Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis
Miquel B Ekkelenkamp, Micha Hanssen, Shang-Te Danny Hsu, Ad de Jong, Dana Milatovic, Jan Verhoef, Nico A J van Nuland FEBS Lett. 2005 Mar 28;579(9):1917-22. doi: 10.1016/j.febslet.2005.01.083.
The potential application of lantibiotics as food-preserving agents and more recently as antibiotics has strongly increased the interest in these antibacterial peptides. Here, we report the elucidation of the primary and three-dimensional structures of the novel lantibiotic epilancin 15X from Staphylococcus epidermidis using high-resolution nuclear magnetic resonance spectroscopy and tandem mass spectrometry. The molecule contains ten post-translationally modified amino acids, three lanthionine ring structures and a hydroxy-propionyl N-terminal moiety. The primary and tertiary structure and the distribution of positive charges are closely similar to the previously identified lantibiotic epilancin K7, most likely indicative of a common mode of action.
Online Inquiry
Verification code
Inquiry Basket